QuarterlyIQ Insights · CNC
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 6 valuation methods, at three horizons. Current price $66.21. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $38.63 | 19.3 | 2.00 | Mgmt | 13 |
| Peer P/FCF | 12M | $266.75 | 20.9 | 12.74 | TTM | 13 |
| Peer P/E | 12M | $48.67 | 19.3 | 2.52 | TTM | 13 |
| PEG | 12M | $220.68 | 87.6 | 2.52 | TTM | 13 |
| Own P/E history | 12M | $30.94 | 12.3 | 2.52 | TTM | 13 |
| triangulated | 12M | $53.35 | 19.3 | 2.76 | Triangulated | 13 |
| Mgmt guidance | 3Y | $115.42 | 19.3 | 5.98 | Mgmt(prov.) | 13 |
| Peer P/FCF | 3Y | $201.72 | 20.9 | 9.63 | Hist. CAGR(prov.) | 13 |
| Peer P/E | 3Y | $145.43 | 19.3 | 7.53 | Analyst | 13 |
| PEG | 3Y | $659.42 | 87.6 | 7.53 | Analyst | 13 |
| Own P/E history | 3Y | $92.46 | 12.3 | 7.53 | Analyst | 13 |
| Mgmt guidance | 5Y | $239.46 | 19.3 | 12.40 | Mgmt(prov.) | 59 |
| Peer P/FCF | 5Y | $167.43 | 20.9 | 8.00 | Hist. CAGR(prov.) | 59 |
| Peer P/E | 5Y | $301.71 | 19.3 | 15.62 | Analyst | 59 |
| Own P/E history | 5Y | $191.82 | 12.3 | 15.62 | Analyst | 59 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.